2.25
2.25 (-1.74%)
As of Jun 14, 2022
Indaptus Therapeutics, Inc. [INDP]
Source:
Company Overview
Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy.We have evolved from more than a century of immunotherapy advances.
| Country | United States |
| Headquarters | new york, new york |
| Phone Number | (646) 427-2727 |
| Industry | |
| CEO | Jeffrey A. Meckler |
| Website | http://www.indaptusrx.com |